Loteace Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid specifically formulated for ophthalmic use. It is indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation following ocular surgery, and anterior uveitis. Loteprednol etabonate exerts its anti-inflammatory effects by inhibiting the release of inflammatory mediators and reducing leukocyte infiltration, thereby alleviating redness, swelling, and discomfort associated with ocular inflammation. The formulation is designed to provide effective local therapy with minimal systemic absorption, reducing the risk of systemic side effects commonly associated with corticosteroids. Loteace Eye Drop should be administered as directed by a healthcare professional, typically instilled into the affected eye(s) multiple times daily depending on the severity of the condition. Caution is advised in patients with ocular infections, glaucoma, or known hypersensitivity to corticosteroids. Prolonged use may increase the risk of elevated intraocular pressure and cataract formation; therefore, regular monitoring by an ophthalmologist is recommended during extended therapy. This medication is contraindicated in viral, fungal, or mycobacterial infections of the eye. Loteace Eye Drop offers a targeted and effective approach to managing ocular inflammation with a favorable safety profile when used appropriately.